Business
Laser Photonics Announces $4 Million Private Placement Priced At-the-Market under Nasdaq Rules
ORLANDO, FL / ACCESS Newswire / September 26, 2025 /Laser Photonics Corporation (NASDAQ:LASE) ("LPC" or the "Company"), $LASE, a global leader in industrial laser systems for cleaning and other material processing applications, today announced that ...
About this update from Laser Photonics Corporation
[{"type":"text","content":"ORLANDO, FL / ACCESS Newswire / September 26, 2025 / Laser Photonics Corporation (NASDAQ:LASE) ("LPC" or the "Company"), $LASE, a global leader in industrial laser systems for cleaning and other material processing applications, today announced that it has entered into definitive agreements for an at-the-market private placement (under NASDAQ rules) for the issuance and sale of:","length":401,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"1,098,902 shares of its common stock, at a purchase price of $3.64 per share,","length":77,"tagName":"p"}]},{"val":[{"type":"text","content":"Series A warrants to purchase up to an aggregate of 1,098,902 shares of common stock at $3.40 per share,","length":104,"tagName":"p"}]},{"val":[{"type":"text","content":"Series B warrants to purchase up to an aggregate of 1,098,902 shares of common stock at $3.40 per share.","length":104,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":285,"olType":false},{"type":"text","content":"The warrants will be exercisable immediately upon issuance. The series A warrants will expire five years after issuance, and the series B warrants will expire eighteen months after issuance.","length":190,"tagName":"p"},{"type":"text","content":"The aggregate gross proceeds to the Company from the offering are expected to be approximately $4 million, before deducting placement agent fees and other offering expenses. The offering is expected to close on or about September 26, 2025, subject to the satisfaction of customary closing conditions.","length":300,"tagName":"p"},{"type":"text","content":"The securities described above were offered in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Act") and Regulation D promulgated thereunder and, along with the shares of common stock underlying the warrants sold in the offering, have not been registered under the Act or applicable state securities laws. Accordingly, such securities may not be offered or sold in the United States absent registration with the SEC or an applicable exemption from such registration requirements. The securities were offered only to accredited investors. Pursuant to a registration rights agreement, the Company has agreed to file one or more registration statements with the SEC covering the resale of th...